Key Information Document Purpose This document provides you with key information about this investment product. It is not marketing material. The information is required by law to help you understand the nature, risks, costs, potential gains and losses of this product and to help you compare it with other products. Product Franklin S&P 500 Screened UCITS ETF Class • ISIN IE0006FAD976 • A sub-fund of Franklin Templeton ICAV Management company (and Manufacturer): Franklin Templeton International Services S.à r.l. ("FTIS"), part of the Franklin Templeton group of companies. Website: www.franklintempleton.lu Call (+352) 46 66 67-1 for more information The Commission de Surveillance du Secteur Financier (CSSF) is responsible for supervising Franklin Templeton International Services S.à r.l. in relation to this Key Information Document. This PRIIP is authorised in Ireland. Date of Production of the KID: 28/04/2025What is this product? Type For more information see www.franklintempleton.ie/41206 The product is a share class of the Sub-fund Franklin S&P 500 ScreenedBase currency US dollar (USD). UCITS ETF (the "Fund") which is part of the Franklin Templeton ICAV (the Benchmark(s) S&P 500 Guarded Index-NR. "Umbrella Fund"), an Irish collective asset-management vehicle constituted The Fund is passively managed and seeks to replicate the benchmark by as an umbrella fund with segregated liability between Sub-Funds with holding all of the index securities in a similar proportion to their weighting in registration number C167746 and authorised by the Central Bank of Ireland the benchmark. Its portfolio, and thus its performance, closely resemble that pursuant to the European Communities (Undertakings for Collective of the benchmark. Investment in Transferable Securities) Regulations 2011. Term Share Class Policy The Fund has no maturity date. The Fund could be closed under the For accumulation shares, income from investments is reinvested in the Fund conditions laid down in the current prospectus of the Fund. and reflected in the price of shares. ObjectivesBuying and selling shares Investment Objective The Fund's shares are listed and traded on one or more stock exchanges. In To provide exposure to large capitalisation stocksin the US with a greaternormal circumstances, only authorised participants (e.g. select financial emphasis on those stocks deemed more environmentally and socially institutions) may deal in shares directly with the Fund. Other investors can responsible. deal in shares daily through a broker on stock exchange(s) on which the shares are traded. Investment Policy Intended retail Investor The Fund invests in equities of companies of large capitalisation in the US Investors who understand the risks of the Fund and plan to invest for at least that are included in the benchmark. 3 to 5 years. The Fund may appeal to investors who: The Index is based on the S&P 500 Index -NR, (the "Parent Index") which is • are looking for long-term investment growth comprised of large cap stocks in the US. The Index is designed to measure the performance of the constituents in the Parent Index that meet the • are interested in exposure to developed equity markets as part of a sustainability criteria defined for the Index. The Index aims to improve the diversified portfolio overall S&P Global ESG Score relative to the Parent Index by over- or • have a high risk profile and can tolerate significant short-term changes in underweighting companies based on their S&P Global ESG Scores. The S&Pthe share price Global ESG Score measures a company's performance on and management Product availability The Fund is available to all investors with at least basic of material ESG risks, opportunities and impacts and considers risks, investment knowledge, through a wide range of distribution channels, with or opportunities and impacts to be material if they present a significant impact without the need for advice. on society or the environment and a significant impact on a company's value drivers, competitive position and long-term shareholder value creation. These are informed by a combination of company disclosures, media andTerms to understand stakeholder analysis, modelling approaches and in-depth companyderivatives: Financial instruments whose value is linked to one or engagement via the S&P Global Corporate Sustainability Assessment, which more rates, indexes, share prices or other values. is an annual evaluation of the sustainability practices of over 13,000 companies. equities: Securities that represent partial ownership of a company. Derivatives and techniques The Fund may use derivatives for hedging and efficient portfolio management.efficient portfolio management: A strategy aimed at reducing risk,lowering costs or generating additional capital or income for the Strategy The investment manager seeks to minimise the difference betweenFund through the use of derivatives. These strategies must align the Fund’s performance and that of the benchmark (tracking error),with the Funds risk profile. regardless of whether the benchmark level rises or falls. SFDR category Article 8 (promotes environmental and/or social characteristics under EU regulations). The benchmark is designed to have a lower carbon intensity and a higher Depositary ESG score than its parent index (S&P World Index-NR). It also excludesState Street Custodial Services (Ireland) Limited. companies involved in controversial business or whose products have Further Information negative social or environmental impacts or are deemed to violate the UN Please refer to the 'Other relevant information' section below. Global Compact Principles or other international norms. Key Information Document Page 1 of 3 What are the risks and what could I get in return? Risk Indicator We have classified this product as 5 out of 7, which is a medium-high risk class. This rates the potential losses from future performance at a medium- high level, and poor market conditions will likely impact the capacity to pay1 2 3 4 5 6 7 you. Be aware of currency risk. In some circumstances, you may receive payment in a different currency, so that the final return you get may depend on the exchange rate between the two currencies. This risk is not consideredLower risk Higher risk in the indicator shown above. Other risks materially relevant to the product not included in the summary risk indicator: • Index related risk The risk indicator assumes you keep the product for 5 year(s). • Secondary market trading risk For a full discussion of all the risks applicable to this Fund, please refer to ! The actual risk can vary significantly if you cash in at an early stage and you may get back less. the "Investment Risk" section of the Fund supplement. This product does not include any protection from future market performance The summary risk indicator is a guide to the level of risk of this product so you could lose some or all of your investment. compared to other products. It shows how likely it is that the product will lose money because of movements in the markets. Performance Scenarios The figures shown include all the costs of the product itself, but may not include all the costs that you pay to your advisor or distributor. The figures do not take into account your personal tax situation, which may also affect how much you get back. What you will get from this product depends on future market performance. Market developments in the future are uncertain and cannot be accurately predicted. The unfavourable, moderate, and favourable scenarios shown are illustrations using the worst, average, and best performance of the product and the suitable benchmark over the last 10 years. Markets could develop very differently in the future. Recommended holding period: 5 years Example Investment:10 000 USD If you exit after 1 year If you exit after 5 years Scenarios Minimum There is no minimum guaranteed return. You could lose some or all of your investment. What you might get back after costs 960 USD 2 370 USD Stress Average return each year -90.40% -25.02% What you might get back after costs 8 120 USD 11 510 USD Unfavourable Average return each year -18.80% 2.85% What you might get back after costs 11 460 USD 18 300 USD Moderate Average return each year 14.60% 12.85% What you might get back after costs 15 540 USD 23 020 USD Favourable Average return each year 55.40% 18.15% The stress scenario shows what you might get back in extreme market circumstances. Unfavourable scenario: This type of scenario occurred for an investment using the benchmark as stated in the prospectus between December 2023 and December 2024. Moderate scenario: This type of scenario occurred for an investment using the benchmark as stated in the prospectus between November 2019 and November 2024. Favourable scenario: This type of scenario occurred for an investment using the benchmark as stated in the prospectus between October 2016 and October 2021. What happens if Franklin Templeton International Services S.à r.l. is unable to pay out? Franklin Templeton International Services S.à r.l. ("FTIS") is the management company of the Fund, but the assets are held separately from FTIS by the depositary. State Street Custodial Services (Ireland) Limited, as the appointed depositary of the Fund, is liable to the Fund or its shareholders for any loss of financial instruments held in custody by it or its delegates (cash could however be lost in case of default of the depositary or its delegates). There is no compensation or guarantee scheme protecting you from a default of the Fund's depositary.What are the costs? The person advising on or selling you this product may charge you other costs. If so, this person will provide you with information about these costs and how they affect your investment. Costs over Time The tables show the amounts that are taken from your investment to cover different types of costs. These amounts depend on how much you invest, how long you hold the product and how well the product does. The amounts shown here are illustrations based on an example investment amount and different possible investment periods. We have assumed: • In the first year you would get back the amount that you invested (0% annual return). For the other holding periods we have assumed the product performs as shown in the moderate scenario • USD 10 000 is invested Key Information Document Page 2 of 3 If you exit after 1 year If you exit after 5 years Total costs11 USD89 USD Annual cost impact (*)0.1%0.1% each year (*) This illustrates how costs reduce your return each year over the holding period. For example it shows that if you exit at the recommended holding period your average return per year is projected to be 12.9% before costs and 12.8% after costs. We may share part of the costs with the person selling you the product to cover the services they provide to you. They will inform you of the amount. Please note that the figures shown here do not include any additional fees that may be charged by your distributor, advisor or any insurance wrapper in which the fund may be placed. Composition of CostsOne-off costs upon entry or exit If you exit after 1 year Entry costs We do not charge an entry fee.0 USD We do not charge an exit fee for this product, but the person selling you the product may do Exit costs0 USD so. Ongoing costs taken each year Management fees and other 0.09% of the value of your investment per year. This is an estimate based on actual costs administrative or operating 9 USD over the last year. costs 0.02% of the value of your investment per year. This is an estimate of the costs incurred Transaction costs when we buy and sell the underlying investments for the product. The actual amount will vary 2 USD depending on how much we buy and sell. Incidental costs taken under specific conditions Performance fees (and carried There is no performance fee for this product. 0 USD interest)How long should I hold it and can I take money out early? Recommended holding period: 5 year(s) This Fund has no minimum required holding period. We consider that the 5 year recommended holding period is appropriate because the Fund is designed for long-term investment. You may sell your shares on any dealing day. The value of your investments may go down as well as up irrespective of the period you are holding your investments, depending on such factors as the performance of the Fund, movements in stock and bond prices, and conditions in financial markets generally. Please contact your broker, financial adviser or distributor for information on any costs and charges relating to the sale of the shares. How can I complain? Investors who would like to receive the procedures relating to complaints handling or wish to make a complaint about the Fund, the operation of FTIS or the person advising on or selling the Fund, should go on the website www.franklintempleton.lu, contact Franklin Templeton International Services, S.à r.l., 8A, rue Albert Borschette L-1246 Luxembourg, or send an e-mail to the client service department at etfteamta@statestreet.com & kure_transaction_monitoring_client_communication@statestreet.com. Other relevant information For further information on the investment objective and policies of the Fund, please refer to the Fund supplement within the current prospectus. Copies of the latest prospectus, including the Fund's supplement, and the latest annual & semi-annual reports of Franklin Templeton ICAV, as well as the latest prices of shares and other information on the Fund (including other share classes of the Fund) are available in English and, selectively, in certain other languages on the website www.franklintempleton.ie, your local Franklin Templeton website, or may be obtained free of charge from the Administrator: State Street Fund Services (Ireland) Limited, 78 Sir John Rogerson's Quay, Dublin 2, Ireland or your financial adviser. Under current legislation, we are not allowed to display performance data for funds with less than a complete full calendar year. Previous performance scenario calculations are available under: - https://docs.data2report.lu/documents/FTI/KID_PP/KID_annex_PP_IE0006FAD976_en.pdf - https://docs.data2report.lu/documents/FTI/KID_PS/KID_annex_PS_IE0006FAD976_en.pdf Key Information Document Page 3 of 3